Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (561-570 of 1,032) with videos related to

Pageof 104
Sort By:
Human Genetics|December 1, 1993
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch populationJ C Defesche, D E van Diermen, P J Lansberg, et al.
Regulatory Peptides|April 3, 2012
Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 ratAdam Whaley-Connell, Javad Habibi, Ravi Nistala, et al.
Journal of Molecular and Cellular Cardiology|March 25, 2022
Inhibition of sphingomyelinase attenuates diet - Induced increases in aortic stiffnessJavad Habibi, Vincent G DeMarco, Jack L Hulse, et al.
Experimental Neurology|December 31, 2003
Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic miceDiana Zala, Jean-Charles Bensadoun, Luis Pereira de Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's diseaseTie-Shan Tang, Elizabeth Slow, Vitalie Lupu, et al.
Human Molecular Genetics|April 22, 2005
Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivoSimon C Warby, Edmond Y Chan, Martina Metzler, et al.
Pain Research & Management|June 11, 2013
Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?Parvaz Madadi, Johanna Sistonen, Gregory Silverman, et al.
American Journal of Medical Genetics|September 1, 1993
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing programM Bloch, S Adam, A Fuller, et al.
Journal of Neuroscience Research|July 12, 2002
Striatal neurochemical changes in transgenic models of Huntington's diseaseMarjorie A Ariano, Neil Aronin, Marian Difiglia, et al.
Gene|September 7, 2000
Human huntingtin-associated protein (HAP-1) gene: genomic organisation and an intragenic polymorphismJ Nasir, M J Lafuente, K Duan, et al.
Pageof 104

Showing results (561-570 of 1,032) with videos related to

Sort By:
Pageof 104
Human Genetics|December 1, 1993
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch populationJ C Defesche, D E van Diermen, P J Lansberg, et al.
Regulatory Peptides|April 3, 2012
Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 ratAdam Whaley-Connell, Javad Habibi, Ravi Nistala, et al.
Journal of Molecular and Cellular Cardiology|March 25, 2022
Inhibition of sphingomyelinase attenuates diet - Induced increases in aortic stiffnessJavad Habibi, Vincent G DeMarco, Jack L Hulse, et al.
Experimental Neurology|December 31, 2003
Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic miceDiana Zala, Jean-Charles Bensadoun, Luis Pereira de Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's diseaseTie-Shan Tang, Elizabeth Slow, Vitalie Lupu, et al.
Human Molecular Genetics|April 22, 2005
Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivoSimon C Warby, Edmond Y Chan, Martina Metzler, et al.
Pain Research & Management|June 11, 2013
Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?Parvaz Madadi, Johanna Sistonen, Gregory Silverman, et al.
American Journal of Medical Genetics|September 1, 1993
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing programM Bloch, S Adam, A Fuller, et al.
Journal of Neuroscience Research|July 12, 2002
Striatal neurochemical changes in transgenic models of Huntington's diseaseMarjorie A Ariano, Neil Aronin, Marian Difiglia, et al.
Gene|September 7, 2000
Human huntingtin-associated protein (HAP-1) gene: genomic organisation and an intragenic polymorphismJ Nasir, M J Lafuente, K Duan, et al.
Pageof 104